Optimization Strategybasic-value-screen
Run this strategy in workspace
Quant Analysis ResultBasic Value ScreenRun Ready

Basic Value Screen

Select holdings using PE, PB, P/FCF, and EV/EBITDA, targeting roughly one quarter of each period's original member count and no more than 20 names; when a period has over 100 members, pre-rank to the top 50 first.

AI Summary

Defensive value tilt with lower market beta, but the optimized plan lags SPY and trails the original screen materially.

Annualized Return
11.95%
Annualized return
Alpha
-1.58%
Active return
Sharpe
0.82
Risk-adjusted return
Beta
0.67
Market sensitivity
Max Drawdown
-18.43%
Maximum drawdown
Top 5
52.81%
Top-5 concentration
Top 10
79.10%
Top-10 concentration
Top 20
100.01%
Top-20 concentration

Portfolio Snapshot

Current optimized weights for the selected default session.

SymbolNameSectorWeightDiff
PGThe Procter & Gamble CompanyConsumer Staples16.91%+16.38
MRKMerck & Co., Inc.Health Care13.75%+13.32
GILDGilead Sciences, Inc.Health Care8.10%+7.84
UBERUber Technologies, Inc.Industrials7.72%+7.47
NEMNewmont CorporationMaterials6.33%+6.13
BMYBristol-Myers Squibb CompanyHealth Care5.69%+5.51
PGRThe Progressive CorporationFinancials5.66%+5.48
ACNAccenture plcInformation Technology5.52%+5.34
ADBEAdobe Inc.Information Technology5.16%+5.00
ADPAutomatic Data Processing, Inc.Industrials4.26%+4.12
UPSUnited Parcel Service, Inc.Industrials3.71%+3.59
RCLRoyal Caribbean Cruises Ltd.Consumer Discretionary3.44%+3.33
AONAon plcFinancials3.33%+3.23
ALLThe Allstate CorporationFinancials2.75%+2.66
AMPAmeriprise Financial, Inc.Financials2.11%+2.04
SYYSysco CorporationConsumer Staples1.72%+1.67
PAYXPaychex, Inc.Industrials1.52%+1.47
NTAPNetApp, Inc.Information Technology1.16%+1.12
GDDYGoDaddy Inc.Information Technology0.61%+0.59
CLXThe Clorox CompanyConsumer Staples0.56%+0.54

Sector Exposure

  • Health Care27.54%
  • Consumer Staples19.19%
  • Industrials17.21%
  • Financials13.85%
  • Information Technology12.45%
  • Materials6.33%
  • Consumer Discretionary3.44%

Weight Changes

Notable position adjustments in the latest snapshot.

  • PGThe Procter & Gamble Company16.91% (+16.38)
  • MRKMerck & Co., Inc.13.75% (+13.32)
  • GILDGilead Sciences, Inc.8.10% (+7.84)
  • UBERUber Technologies, Inc.7.72% (+7.47)
  • NEMNewmont Corporation6.33% (+6.13)
  • BMYBristol-Myers Squibb Company5.69% (+5.51)
  • PGRThe Progressive Corporation5.66% (+5.48)
  • ACNAccenture plc5.52% (+5.34)
  • ADBEAdobe Inc.5.16% (+5.00)
  • ADPAutomatic Data Processing, Inc.4.26% (+4.12)
  • UPSUnited Parcel Service, Inc.3.71% (+3.59)
  • RCLRoyal Caribbean Cruises Ltd.3.44% (+3.33)
  • AONAon plc3.33% (+3.23)
  • ALLThe Allstate Corporation2.75% (+2.66)
  • AMPAmeriprise Financial, Inc.2.11% (+2.04)
  • SYYSysco Corporation1.72% (+1.67)
  • PAYXPaychex, Inc.1.52% (+1.47)
  • NTAPNetApp, Inc.1.16% (+1.12)
  • GDDYGoDaddy Inc.0.61% (+0.59)
  • CLXThe Clorox Company0.56% (+0.54)

Performance vs Benchmark

Strategy NAV vs benchmark — hover for exact values.

Basic Value ScreenBenchmark

Alpha Trend

Excess return vs benchmark over time.

Alpha (positive)Alpha (negative)

Drawdown Trend

Underwater curve and peak drawdown marker.

Max DD: -18.43%(Apr 25)

Turnover Trend

Per-period turnover with average reference.

Avg turnover: 47.47Peak: 81.28

Strategy Comparison

All four default strategies side-by-side.

StrategyAnnualizedAlphaSharpeMax DD
Baseline21.38%0.04%1.37-18.86%
Momentum Screen22.03%0.17%1.17-22.18%
Basic Value Screen11.95%-1.58%0.82-18.43%
Combo Equal Screen24.09%-0.26%1.23-22.99%

vs Baseline: Annualized -9.43 · Alpha -1.63 · Sharpe -0.55

Recent Periods

Per-period performance vs benchmark.

PeriodStrategyBenchmarkExcessTurnoverTrades
2025-05-313.09%3.75%-0.6612.5621
2025-06-30-0.73%2.69%-3.4261.8425
2025-07-315.91%2.05%+3.8536.1723
2025-08-312.75%3.66%-0.9051.2024
2025-09-30-1.09%2.05%-3.1478.8424
2025-10-315.44%0.20%+5.2572.4623
2025-11-302.43%0.99%+1.4457.8923
2025-12-313.47%1.47%+1.9941.4524
2026-01-313.55%-1.35%+4.9063.6125
2026-02-28-8.43%-7.93%-0.5053.8423
2026-03-318.45%9.42%-0.9738.7922
2026-04-30-0.30%4.11%-4.4054.6821

Strategy Q&A

Pre-generated questions and answers about this strategy.

  • value13FChat AI

    Are the selected value names mean-reversion opportunities or possible value traps?

    Recent period evidence is mixed by design: the strongest period was 2025-10-31 (5.44% strategy return, 0.20% benchmark, 5.25% excess, 72.46% turnover), and the weakest was 2026-04-30 (-0.30% strategy return, 4.11% benchmark, -4.40% excess, 54.68% turnover). With turnover around 47.47% and latest changes of PG increase to 16.91%; MRK increase to 13.75%; GILD increase to 8.10%, the user should verify whether each selected name has improving fundamentals, not just a low multiple.

    strategyViews.basic-value-screen.periodPerformancestrategyViews.basic-value-screen.latestChanges

    Identify whether each selected value name has improving fundamentals or only a low valuation multiple.

  • value13FChat AI

    Did the value screen improve valuation exposure without hurting return quality?

    The value screen reports return 11.95%, alpha -1.58%, beta 0.67, Sharpe 0.82, Sortino 1.25, and max drawdown -18.43%. Relative to baseline, annualized return changed by -9.43%, alpha changed by -1.63%, Sharpe changed by -0.55, Sortino changed by -0.57, drawdown improved by 0.44%. The key question is whether lower valuation exposure is worth any sacrifice in growth, momentum, or quality leadership.

    strategyViews.basic-value-screen.metricsstrategyViews.baseline.metrics

    Review PE, PB, FCF yield, return quality, and momentum for the value-screen names.

  • value13FChat AI

    Did the value screen reduce concentration or simply rotate into another concentrated bet?

    The selected value book has top 5 52.81%, top 10 79.10%, top 20 100.01%, versus baseline top 5 30.72%, top 10 40.65%, top 20 50.14%. Its largest positions are PG (The Procter & Gamble Company) 16.91%, MRK (Merck & Co., Inc.) 13.75%, GILD (Gilead Sciences, Inc.) 8.10%, and UBER (Uber Technologies, Inc.) 7.72%, so concentration risk still needs to be reviewed even if the names look cheaper.

    strategyViews.basic-value-screen.concentrationstrategyViews.baseline.concentration

    Compare value-screen top weights with baseline top weights and identify the largest reallocations.

Other strategies for this fund

This content is for informational and research purposes only and is not investment advice.